S
Sverre E. Kjeldsen
Researcher at University of Oslo
Publications - 771
Citations - 95426
Sverre E. Kjeldsen is an academic researcher from University of Oslo. The author has contributed to research in topics: Blood pressure & Left ventricular hypertrophy. The author has an hindex of 94, co-authored 735 publications receiving 89059 citations. Previous affiliations of Sverre E. Kjeldsen include University of Michigan & Cornell University.
Papers
More filters
Journal ArticleDOI
In memoriam Eivind Berge, MD, PhD, 1964–2020: cardiologist, trialist and hypertension/stroke researcher
Journal ArticleDOI
High blood pressure in US diabetic veterans with normal renal function: a plea for the design of a more powerful and conclusive outcome trial.
Sverre E. Kjeldsen,Ingrid Os +1 more
TL;DR: Today it is mostly a question of how low BP should be lowered in patients with diabetes to optimally protect against cardiovascular and renal disease, though a well designed trial with proper statistical power is yet to be carried out.
Journal ArticleDOI
Treatment of high blood pressure in acute stroke--the SCAST study.
TL;DR: Blood pressure declined in both groups during the treatment period, but was signifi cantly lower in the patients who were allocated to candesartan, and functional outcome at 6 months, as measured by the modifi ed Rankin Scale (mRS).
Book ChapterDOI
Prevention and Treatment of Atrial Fibrillation in Patients with Hypertension
TL;DR: Hypertension is the main risk factor for the development of AF due to progression of structural changes, neuro-hormonal activation, fibrosis and atherosclerosis, and some antihypertensive drug classes may be superior to others in the prevention of new onset-AF and prevention of stroke.
Journal ArticleDOI
Hypertension: When should we treat hypertension in patients with diabetes?
Sverre E. Kjeldsen,Ingrid Os +1 more
TL;DR: An extensive review of the use of blood-pressure-lowering drugs in patients with diabetes supports treating blood pressure >140/90 mmHg, whereas reducing blood pressure in people with normal or high–normal blood pressure might have untoward effects.